March 18, 2014
The Federal Circuit on Tuesday affirmed a lower court's ruling that generics maker Barr Laboratories Inc. did not infringe two Alcon Research Ltd. patents covering the glaucoma drug Travatan Z, but reversed the court's finding that the patents were invalid.